The association between prior percutaneous coronary intervention and short-term outcomes after coronary artery bypass

Ansar Hassan1, Karen J Buth, Roger J F Baskett

  • 1Division of Cardiac Surgery, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.

American Heart Journal
|November 18, 2005
PubMed

Insights

Prior percutaneous coronary intervention (PCI) increases in-hospital mortality risk following coronary artery bypass grafting (CABG). This finding holds true even after accounting for patient differences, highlighting PCI as an independent predictor of adverse outcomes post-CABG.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Interventional Cardiology

Background:

  • Increasing numbers of patients undergo coronary artery bypass grafting (CABG) after prior percutaneous coronary intervention (PCI).
  • The impact of prior PCI on outcomes following CABG requires thorough investigation.

Purpose of the Study:

  • To assess the effect of prior percutaneous coronary intervention (PCI) on in-hospital mortality rates among patients undergoing coronary artery bypass grafting (CABG).

Main Methods:

  • A comparative analysis of perioperative data from patients undergoing first-time CABG at two surgical centers.
  • Exclusion of patients who underwent PCI and CABG during the same hospital admission.
  • Risk-adjusted analysis using multivariate techniques and propensity score matching to compare outcomes between patients with and without prior PCI.

Main Results:

  • Patients with prior PCI were less likely to have comorbidities like reduced ejection fraction or multi-vessel disease but more likely to present with advanced symptoms and urgent status.
  • In-hospital mortality rates after CABG were significantly higher in the prior PCI group (3.6% vs. 2.3%).
  • Prior PCI was identified as an independent predictor of in-hospital mortality (OR 1.93, P=0.003) and remained significant after propensity score matching (3.6% vs. 1.7%, P=0.01).

Conclusions:

  • Despite presenting with fewer comorbidities, patients with prior PCI undergoing CABG experience higher in-hospital mortality.
  • Prior PCI is an independent risk factor for in-hospital mortality after CABG, even after adjusting for clinical differences.
  • These findings underscore the importance of considering prior PCI when evaluating surgical risk for CABG.
Abstract

Related Concept Videos

Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...